L Huang1,2, J Bai3, R Zong1, J Zhou1, Z Zuo4,5,6, X Chai4,5,6, Z Wang4,5,6, J An7, Y Zhuo4,5,6, F Boada8, X Yu1, Z Ling1, B Qu3, L Pan9, Z Zhang4,5,6. 1. From the Departments of Neurosurgery (L.H., R.Z., J.Z., X.Y., Z.L., L.P.). 2. Department of Neurosurgery (L.H.), The Hospital of 81st Group Army PLA, Zhangjiakou, China. 3. Radiation Oncology (J.B., B.Q.), The First Medical Center of PLA General Hospital, Beijing, China. 4. State Key Laboratory of Brain and Cognitive Science (Z. Zou., X.C., Z.W., Y. Z., Z. Zhang.), Institute of Biophysics, Chinese Academy of Sciences, Beijing, China. 5. University of Chinese Academy of Sciences (Z. Zou., X.C., Z.W., Y. Z., Z. Zhang.), Beijing, China. 6. CAS Center for Excellence in Brain Science and Intelligence Technology (Z. Zou., X.C., Z.W., Y. Z., Z. Zhang.), Chinese Academy of Sciences, Beijing, China. 7. Siemens Shenzhen Magnetic Resonance Ltd (J.A.), Shenzhen, China. 8. Department of Radiology (F.B.), Center for Advanced Imaging Innovation and Research, New York University Grossman School of Medicine, New York, New York. 9. From the Departments of Neurosurgery (L.H., R.Z., J.Z., X.Y., Z.L., L.P.) panls301@163.com.
Abstract
BACKGROUND AND PURPOSE: Conventionally, early treatment response to stereotactic radiotherapy in intracranial tumors is often determined by structural MR imaging. Tissue sodium concentration is altered by cellular integrity and energy status in cells. In this study, we aimed to investigate the feasibility of sodium MR imaging at 7T for the preliminary evaluation of radiotherapeutic efficacy for intracranial tumors. MATERIALS AND METHODS: Data were collected from 16 patients (12 men and 4 women, 24-75 years of age) with 22 intracranial tumors who were treated with stereotactic radiation therapy using CyberKnife at our institution between December 1, 2016, and August 15, 2019. Sodium MR imaging was performed at 7T before and 48 hours, 1 week, and 1 month after CyberKnife radiation therapy. Tissue sodium concentration (TSC) was calculated and analyzed based on manually labeled regions of tumors. RESULTS: Ultra-high-field sodium MR imaging clearly showed the intratumoral signal, which is significantly higher than that of normal tissue (t = 5.250, P <.001)., but the edema zone has some influence. The average TSC ratios of tumor to CSF in the 22 tumors, contralateral normal tissues, edema zones, frontal cortex, and frontal white matter were 0.66 (range, 0.23-1.5), 0.30 (range, 0.15-0.43), 0.58 (range, 0.25-1.21), 0.25 (range, 0.17-0.42), and 0.30 (range, 0.19-0.49), respectively. A total of 12 tumors in 8 patients were scanned at 48 hours, 1 week, and 1 month after treatment. The average TSC at 48 hours after treatment was 0.06 higher than that before treatment and began to decrease at 1 week. The TSC ratios of 10 continued to decline and 2 tumors increased at 1 month, respectively. Tumor volume decreased by 2.4%-99% after 3 months. CONCLUSIONS: Changes in the TSC can be quantified by sodium MR imaging at 7T and used to detect radiobiologic alterations in intracranial tumors at early time points after CyberKnife radiation therapy.
BACKGROUND AND PURPOSE: Conventionally, early treatment response to stereotactic radiotherapy in intracranial tumors is often determined by structural MR imaging. Tissue sodium concentration is altered by cellular integrity and energy status in cells. In this study, we aimed to investigate the feasibility of sodium MR imaging at 7T for the preliminary evaluation of radiotherapeutic efficacy for intracranial tumors. MATERIALS AND METHODS: Data were collected from 16 patients (12 men and 4 women, 24-75 years of age) with 22 intracranial tumors who were treated with stereotactic radiation therapy using CyberKnife at our institution between December 1, 2016, and August 15, 2019. Sodium MR imaging was performed at 7T before and 48 hours, 1 week, and 1 month after CyberKnife radiation therapy. Tissue sodium concentration (TSC) was calculated and analyzed based on manually labeled regions of tumors. RESULTS: Ultra-high-field sodium MR imaging clearly showed the intratumoral signal, which is significantly higher than that of normal tissue (t = 5.250, P <.001)., but the edema zone has some influence. The average TSC ratios of tumor to CSF in the 22 tumors, contralateral normal tissues, edema zones, frontal cortex, and frontal white matter were 0.66 (range, 0.23-1.5), 0.30 (range, 0.15-0.43), 0.58 (range, 0.25-1.21), 0.25 (range, 0.17-0.42), and 0.30 (range, 0.19-0.49), respectively. A total of 12 tumors in 8 patients were scanned at 48 hours, 1 week, and 1 month after treatment. The average TSC at 48 hours after treatment was 0.06 higher than that before treatment and began to decrease at 1 week. The TSC ratios of 10 continued to decline and 2 tumors increased at 1 month, respectively. Tumor volume decreased by 2.4%-99% after 3 months. CONCLUSIONS: Changes in the TSC can be quantified by sodium MR imaging at 7T and used to detect radiobiologic alterations in intracranial tumors at early time points after CyberKnife radiation therapy.
Authors: Fernando E Boada; George LaVerde; Charles Jungreis; Edwin Nemoto; Costin Tanase; Ileana Hancu Journal: Curr Top Dev Biol Date: 2005 Impact factor: 4.897
Authors: Stefan Haneder; Frank A Giordano; Simon Konstandin; Stefanie Brehmer; Karen A Buesing; Peter Schmiedek; Lothar R Schad; Frederik Wenz; Stefan O Schoenberg; Melissa M Ong Journal: Neuroradiology Date: 2014-11-27 Impact factor: 2.804
Authors: Stephen C Jones; Alexander Kharlamov; Boris Yanovski; D Kyle Kim; Kirk A Easley; Victor E Yushmanov; Scott K Ziolko; Fernando E Boada Journal: Stroke Date: 2006-01-19 Impact factor: 7.914
Authors: A Baethmann; K Maier-Hauff; L Schürer; M Lange; C Guggenbichler; W Vogt; K Jacob; O Kempski Journal: J Neurosurg Date: 1989-04 Impact factor: 5.115